“…It is well known that higher HDL‐C levels protect from future cardiovascular events [23–25] and its therapeutic elevation is associated with plaque regression on intravascular ultrasound studies [26]. Data are less conclusive concerning its interrelationship with CAD prevalence or even severity, with some studies reporting a significant association [27–35] and others not [36–38]. Altogether, the number of patients with angiographic evaluation of CAD in these reports was much lower than in our study.…”
In this large consecutive patient cohort, HDL-C and CRP are independently associated with the prevalence of CAD. In this analysis, HDL-C is an even stronger predictor for CAD than some other major classical risk factors.
“…It is well known that higher HDL‐C levels protect from future cardiovascular events [23–25] and its therapeutic elevation is associated with plaque regression on intravascular ultrasound studies [26]. Data are less conclusive concerning its interrelationship with CAD prevalence or even severity, with some studies reporting a significant association [27–35] and others not [36–38]. Altogether, the number of patients with angiographic evaluation of CAD in these reports was much lower than in our study.…”
In this large consecutive patient cohort, HDL-C and CRP are independently associated with the prevalence of CAD. In this analysis, HDL-C is an even stronger predictor for CAD than some other major classical risk factors.
“…Second, the severity of CAD was assessed based on a visual interpretation of the number of diseased vessels instead of using validated scoring system including SYNTAX score or Gensini score, or evaluating for functional ischemia. Although visual assessment of lesion severity is inherently subjective and may result in over-or underestimation, the number of diseased vessels according to visual assessment has been shown to be associated with prognosis [1][2][3]. Lastly, we did not have the data regarding time from symptom onset to presentation.…”
Section: Discussionmentioning
confidence: 99%
“…Patients with acute coronary syndrome due to left main and/or three-vessel disease (LM/3VD) are at the highest risk of short-and long-term adverse cardiovascular events [1][2][3]. In contrast to the welldefined indication for an emergent coronary angiography in ST elevation myocardial infarction (STEMI) population, there is still an uncertainty regarding the optimal timing of angiography in non-ST-elevation myocardial infarction (NSTEMI) patients, and ischemiaguided strategy is an appropriate strategy for selected low-risk patients [4].…”
“…11 Inclusion criteria for the study were (1) a troponin level greater than the 99th percentile reference value before cardiac catheterization; (2) chest pain (or anginal equivalent) or ischemic change on the electrocardiogram (ECG) including horizontal or down-sloping ST-segment depression (ࣙ0.05 mV) or T-wave inversion (ࣙ0.1 mV) in two or more contiguous leads; and (3) absence of ST-segment elevation and new left bundle branch block on the ECG. Myocardial infarction (MI) was diagnosed according to the criteria of the European Society of Cardiology and American College of Cardiology.…”
Section: Methodsmentioning
confidence: 99%
“…[1][2][3] Early recognition of patients with LM/3VD is crucial for disease management including coronary angiogram and revascularization, as well as choice of pharmacological agents. [1][2][3] Early recognition of patients with LM/3VD is crucial for disease management including coronary angiogram and revascularization, as well as choice of pharmacological agents.…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.